Macrolide-Resistant Mycoplasma pneumoniae in Children, Ohio, USA.

ABSTRACT: As the COVID-19 pandemic waned, Mycoplasma pneumoniae reemerged in the pediatric population in Ohio, USA. The rate of macrolide-resistant M. pneumoniae fluctuated by month, ranging from 0 to 8.7%, and mirrored the azithromycin prescribing rate. Real-time surveillance for macrolide-resistant M. pneumoniae provides accurate information for management of children with these infections.

SUBMITTER: Wang H 

PROVIDER: S-EPMC12782270 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature